Tomasz Laskus
Overview
Explore the profile of Tomasz Laskus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
1001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Makowiecki M, Paciorek M, Bednarska A, Krogulec D, Porowski D, Bursa D, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768768
: The aim of this study was to evaluate the association between various clinical and laboratory findings and in-hospital mortality in community-acquired bacterial meningitis (BM). : We retrospectively analyzed 339...
2.
Jurasz H, Bukowska-Osko I, Rydzanicz M, Popiel M, Dzieciatkowski T, Bakula-Grzadka K, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456958
virus (TTV) is a ssDNA orphan virus belonging to the family, but some recent studies suggested its possible involvement in central nervous system (CNS) pathology. We analyzed serum and cerebrospinal...
3.
Pawlowski T, Radkowski M, Perlejewski K, Laskus T, Malyszczak K
Psychosom Med
. 2024 Jan;
86(2):124-128.
PMID: 38193776
Background: Sustained virological response (SVR) is the best indicator of successful therapy for hepatitis C virus (HCV) infection. Patients with chronic HCV infection treated with pegylated interferon-α and ribavirin (PEG-IFN-α/RBV)...
4.
Radkowski M, Grabarczyk P, Kryczka T, Caraballo Cortes K, Kubicka-Russel D, Janiak M, et al.
Sci Rep
. 2023 Nov;
13(1):20045.
PMID: 37973814
Most Hepatitis C virus (HCV)-infected subjects develop chronic infection, whereas a minority clear the virus in the early phase of infection. We analyzed factors associated with outcome (chronicity vs clearance)...
5.
Radkowski M, Kryczka T, Szymanska-Kotwica B, Berak H, Horban A, Pawlowski T, et al.
Int J Mol Sci
. 2023 Oct;
24(20).
PMID: 37895030
Chronic hepatitis C virus (HCV) infection is commonly associated with depression and cognitive dysfunction, the cause of which could be related to the HCV neuroinvasion and/or state of chronic inflammation....
6.
Perlejewski K, Radkowski M, Pawelczyk A, Rydzanicz M, Dzieciatkowski T, Makowiecki M, et al.
Ticks Tick Borne Dis
. 2023 Sep;
14(6):102253.
PMID: 37729847
Patients with Lyme neuroborreliosis (LNB) are rarely tested for the presence of neurovirulent viruses other than tick-borne encephalitis virus (TBEV); however, such coinfections could be of clinical importance. The aim...
7.
Perlejewski K, Radkowski M, Rydzanicz M, Dzieciatkowski T, Silling S, Wieczorek M, et al.
J Neurovirol
. 2023 Jul;
29(5):588-597.
PMID: 37490185
Little is known about concomitant central nervous system (CNS) infections by more than one virus. Current diagnostics are based on molecular tests for particular pathogens making it difficult to identify...
8.
Pawlowski T, Malyszczak K, Pawlak D, Inglot M, Zalewska M, Grzywacz A, et al.
Cells
. 2023 Mar;
12(6).
PMID: 36980311
Background: Seeing that there are no data about associations between serotonin gene polymorphism and tryptophan catabolite concentration during PEG-IFN-α2a treatment, the aim of the current study is to examine (a)...
9.
Grochowska M, Laskus T, Paciorek M, Pollak A, Lechowicz U, Makowiecki M, et al.
Curr Issues Mol Biol
. 2022 Jul;
44(7):2903-2914.
PMID: 35877424
There are multiple lines of evidence for the existence of communication between the central nervous system (CNS), gut, and intestinal microbiome. Despite extensive analysis conducted on various neurological disorders, the...
10.
Osuch S, Laskus T, Perlejewski K, Berak H, Bukowska-Osko I, Pollak A, et al.
Front Immunol
. 2022 Apr;
13:832206.
PMID: 35386708
Background And Aims: During chronic hepatitis C virus (HCV) infection, CD8 T-cells become functionally exhausted, undergoing progressive phenotypic changes, i.e., overexpression of "inhibitory" molecules such as PD-1 (programmed cell death...